-
Mashup Score: 0
Background Atrial fibrillation (AF) is a major and increasing burden on health services. This study aimed to evaluate the cost-effectiveness of digoxin versus beta-blockers for heart rate control in patients with permanent AF and symptoms of heart failure. Methods RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) was a randomised, open-label, blinded, endpoint trial embedded in the UK National Health Service (NHS) to directly compare low-dose digoxin with beta-blockers (ClinicalTrials.gov: [NCT02391337][1]). A trial-based cost-utility analysis was performed from a healthcare perspective over 12 months. Resource use in primary and secondary healthcare services, medications and patient-reported quality of life were prospectively collected to estimate differences in costs and quality-adjusted life years (QALYs). Results RATE-AF randomised 160 patients with mean age of 76 (SD 8) years and 46% women, of which 149 patients (n=73 digoxin, n=76 beta blockers) had compl
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct oral anticoagulant in pati…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation https://t.co/JeGHwNtbRw #Afib via @NEJM
-
-
Mashup Score: 7Practical Applications of the 2023 Guidelines for the Diagnosis and Management of Patients with Afib - 4 day(s) ago
A live symposium presented at the 2024 ASPC Congress on CVD Prevention in Salt Lake City, UT. Program presented by:Ravi Ranjan, MD, PhD, FHRS and Libo Wang, …
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
Explore the "Practical Applications of the 2023 Afib Diagnosis & Management Guidelines." đź©ş Ravi Ranjan, MD, PhD, FHRS đź©ş Libo Wang, MD (University of Utah) đź“– Watch now: https://t.co/3unZrYQw2B #Afib https://t.co/GjuDK6yIQi
-
-
Mashup Score: 6
Background Atrial fibrillation (AF) is a major risk factor for ischemic stroke, and early AF diagnosis may reduce associated morbidity and mortality. A 10-variable predictive model (UNAFIED) was previously developed to estimate patients’ 2-year AF risk. This study evaluated a clinical workflow incorporating UNAFIED for screening, education, and follow-up evaluation of patients visiting a cardiology clinic who may be at an elevated risk of developing AF within 2 years. Methods Patients were included if they were aged ≥ 40 years with a scheduled in-person visit at the Eskenazi Health Cardiology Clinic between October 25, 2021, and August 10, 2022. Clinical decision support identified patients with an elevated AF risk. Initial screening with 1-lead electrocardiogram devices was offered, and routine clinical practice for diagnosis and management was followed. Physicians were surveyed on their use of the workflow, attitudes toward implementation, and perceived impact on patient care. Result
Categories: General Medicine News, CardiologistsTweet-
Screening for undiagnosed atrial fibrillation using an electronic health record‒based clinical prediction model: clinical pilot implementation initiative | EHR+AI+Kardia = clinically valuable screening for #Afib. https://t.co/AaNVku2n1P
-
-
Mashup Score: 13AV Node Ablation for AF in Conduction System Pacing: Key Points - American College of Cardiology - 1 month(s) ago
Sherrie R. Webb, PA-C
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
In patients w/ persistent #AFib refractory to other treatments, implantation of a permanent pacemaker & atrioventricular node ablation (AVNA) is a reasonable second-line strategy. Read more on AVNA for AFib in conduction system pacing! 👇 https://t.co/mJaNEr9F15
-
-
Mashup Score: 7Practical Applications of the 2023 Guidelines for the Diagnosis and Management of Patients with Afib - 1 month(s) ago
A live symposium presented at the 2024 ASPC Congress on CVD Prevention in Salt Lake City, UT. Program presented by:Ravi Ranjan, MD, PhD, FHRS and Libo Wang, …
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
Explore the "Practical Applications of the 2023 Afib Diagnosis & Management Guidelines." đź©ş Ravi Ranjan, MD, PhD, FHRS đź©ş Libo Wang, MD (University of Utah) đź“– Watch now: https://t.co/3unZrYQw2B #Afib https://t.co/GjuDK6yIQi
-
-
Mashup Score: 1Texas Cardiac Arrhythmia Institute becomes first in USA to use FDA-approved mapping and dual-energy ablation catheter - 2 month(s) ago
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St David’s Medical Center (Austin, USA) recently became the first in the USA to use an all-in-one, high-density mapping and dual-energy ablation catheter (Affera [Medtronic]) for the treatment of persistent atrial fibrillation (AF) and atrial flutter following its receipt of approval by the US Food and […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
Electrophysiologists at @tcainstitute recently became the first in the USA to use an all-in-one, high-density mapping and dual-energy ablation catheter for the treatment of persistent #AFib and atrial flutter following its receipt of @US_FDA approval https://t.co/L3LktdR0Fx
-
-
Mashup Score: 0COVID-19 vaccination “generally not associated” with increased thromboembolic event risk in AF and atrial flutter patients - 2 month(s) ago
In patients with atrial fibrillation (AF) or atrial flutter, COVID-19 vaccination appears to be “generally not associated with an increased risk of thromboembolic events”, as per the findings of a recent study led by researchers in South Korea. In addition to their study’s main conclusion, the researchers note—writing in the European Heart Journal—that “careful individual […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
In patients with #AFib or atrial flutter, COVID-19 vaccination appears to be “generally not associated with an increased risk of thromboembolic events”, as per the findings of a recent study led by researchers in South Korea @ehj_ed @ESC_Journals https://t.co/vGF9GLNfWK
-
-
Mashup Score: 2
Dr Kunal Kapoor and colleagues discuss their approach to same-day discharge after atrial fibrillation ablation at Emory University.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet-
Same-Day Discharge: An Evolving Landscape for #AFib Ablations  Read the article in EP Lab DIgest's November issue and on the Early Ambulation & Same Day Discharge Topic Center! https://t.co/S6yU8R0FVe @HaemoneticsCorp https://t.co/5qYHZMfQap
-
-
Mashup Score: 12Assessment of Flecainide to Lower the patent foramen Ovale closure risk of Atrial fibrillation or Tachycardia - American College of Cardiology - 3 month(s) ago
Dharam J. Kumbhani, MD, SM, FACC
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
The AFLOAT trial showed that atrial arrhythmias were commonly noted post-PFO closure on systematic intracardiac monitoring, but flecainide did not reduce the incidence of these atrial arrhythmias. Get the details of the clinical trial here: https://t.co/OLNIdizMnk #AFib
-
Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial https://t.co/Xnm4FzihRr #Afib via @Heart_BMJ